391 related articles for article (PubMed ID: 18090872)
21. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
[TBL] [Abstract][Full Text] [Related]
22. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J
Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336
[TBL] [Abstract][Full Text] [Related]
23. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
24. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
[TBL] [Abstract][Full Text] [Related]
25. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
[TBL] [Abstract][Full Text] [Related]
26. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
27. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
28. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
[TBL] [Abstract][Full Text] [Related]
29. Transdermal estrogen reduces vascular resistance and serum cholesterol in postmenopausal women.
West SG; Hinderliter AL; Wells EC; Girdler SS; Light KC
Am J Obstet Gynecol; 2001 Apr; 184(5):926-33. PubMed ID: 11303200
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
32. Hormone therapy and postural balance in elderly women.
Naessen T; Lindmark B; Larsen HC
Menopause; 2007; 14(6):1020-4. PubMed ID: 17595592
[TBL] [Abstract][Full Text] [Related]
33. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
34. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
Fait T; Vrablik M; Zizka Z; Kostirova M
Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
37. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
38. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
39. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
Bruschi F; Dal Pino D; Fiore V; Parazzini F; Di Pace R; Cesana BM; Melotti D; Crosignani PG
Maturitas; 2004 May; 48(1):33-8. PubMed ID: 15223106
[TBL] [Abstract][Full Text] [Related]
40. Short-term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women.
Chao HT; Kuo CD; Su YJ; Chuang SS; Fang YJ; Ho LT
Fertil Steril; 2005 Nov; 84(5):1477-83. PubMed ID: 16275247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]